Compounds > trovafloxacin
Page last updated: 2024-08-24

trovafloxacin and Bacterial Infections, Gram-Positive

trovafloxacin has been researched along with Bacterial Infections, Gram-Positive in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's9 (60.00)18.2507
2000's6 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eliopoulos, CT; Eliopoulos, GM; Ferraro, MJ; Klimm, K; Moellering, RC1
Bonilla, HF; Bradley, SF; Kauffman, CA; Zarins, LT1
Brighty, KE; Gootz, TD1
Dudley, MN; Gilbert, D; Zinner, SH1
Montgomerie, JZ; Schick, DG1
Gootz, TD; Pechère, JC1
Alperstein, P; France, K; Isenberg, HD1
Beach, ML; Doern, GV; Jones, RN; Pfaller, MA1
Seifert, H1
Amsterdam, D; Hardy, D; Mandell, LA; Rotstein, C1
Bjarnason, J; Blondeau, JM; Laskowski, R; Stewart, C1
Eckert, SJ; McNeeley, DF; Noel, GJ1
Barzilai, A; Diamantstein, L; Gruzman, G; Keller, N; Rubinovitch, B; Rubinstein, E; Yoseph, G1
Goessens, WH; Gyssens, IC; Mouton, JW; Oyen, WJ; Stearne, LE; van der Meer, JW; Verbrugh, HA1
Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM1

Reviews

2 review(s) available for trovafloxacin and Bacterial Infections, Gram-Positive

ArticleYear
The chemistry and biological profile of trovafloxacin.
    The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl B

    Topics: Animals; Anti-Infective Agents; Bacteria, Anaerobic; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Guinea Pigs; Humans; Macaca fascicularis; Mice; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Structure-Activity Relationship

1997
Bacteriological activity of trovafloxacin, a new quinolone, against respiratory tract pathogens.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:6

    Topics: Animals; Anti-Infective Agents; Drug Resistance, Microbial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Naphthyridines; Respiratory System; Respiratory Tract Infections

1998

Other Studies

13 other study(ies) available for trovafloxacin and Bacterial Infections, Gram-Positive

ArticleYear
In vitro activity of CP-99,219, a new fluoroquinolone, against clinical isolates of gram-positive bacteria.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:2

    Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines

1993
Susceptibility of ciprofloxacin-resistant staphylococci and enterococci to trovafloxacin.
    Diagnostic microbiology and infectious disease, 1996, Volume: 26, Issue:1

    Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Methicillin; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Staphylococcal Infections; Staphylococcus aureus

1996
Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Ampicillin; Anti-Infective Agents; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Naphthyridines; Sulbactam

1998
Treatment of enterococcal pyelonephritis with trovafloxacin and rifampin: in vitro-in vivo contrast.
    Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Drug Interactions; Drug Therapy, Combination; Enterococcus faecalis; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Naphthyridines; Pyelonephritis; Rats; Rats, Sprague-Dawley; Rifampin

1998
In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
    Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:2

    Topics: Anti-Infective Agents; Ciprofloxacin; Corynebacterium; Drug Resistance, Microbial; Fluoroquinolones; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin

1998
Antimicrobial activity of gatifloxacin tested against 1676 strains of ciprofloxacin-resistant gram-positive cocci isolated from patient infections in North and South America.
    Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:3

    Topics: Anti-Infective Agents; Antitubercular Agents; Bacteriological Techniques; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Naphthyridines; North America; Quinolones; South America

1998
Comparative in-vitro activities of trovafloxacin, ciproflaxacin, ofloxacin, and broad-spectrum beta-lactams against aerobe blood culture isolates.
    Zentralblatt fur Bakteriologie : international journal of medical microbiology, 1998, Volume: 288, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Bacteria, Aerobic; Bacterial Infections; beta-Lactams; Blood; Culture Media; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Naphthyridines

1998
Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:3

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Fluoroquinolones; Gemifloxacin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines

2000
Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms.
    International journal of antimicrobial agents, 2000, Volume: 14, Issue:1

    Topics: Anti-Infective Agents; Aza Compounds; Drug Resistance, Microbial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines

2000
Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
    The Pediatric infectious disease journal, 2000, Volume: 19, Issue:7

    Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Naphthyridines; Penicillins; Vancomycin

2000
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2000, Volume: 6, Issue:12

    Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Globulins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suppuration

2000
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:5

    Topics: Abscess; Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Blood Proteins; Disease Models, Animal; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Immunoglobulin G; Mice; Mice, Inbred BALB C; Naphthyridines; Treatment Outcome; Vancomycin Resistance

2001
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
    Chemotherapy, 2001, Volume: 47, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin

2001